Research & Development

While companies are investing in technology and analytics, these investments haven’t always produced the results expected – requiring pharmaceutical companies to look for new ways to improve the impact of this technology and new data in driving efficiency and value.

The evidence now required to support a pharmaceutical brand is becoming far more complex. Because pharmaceutical companies need to further prove to payers, physicians, and patients the value of their therapies, they need to create a more comprehensive strategy for developing evidence throughout the lifecycle of the brand, not just during clinical trials, but in the real world as well.